Four things to know:
1. The X-Bolt device is designed to reduce reoperation rates. The implant features wings that expand in situ to offer a rotationally stronger and more secure femoral bone anchorage than traditional screw fixation.
2. The 1,000th patient completed one-year of follow-up in the World Hip Trauma Evaluation 4 trial, in which hip fracture patients were randomized to receive either a gold standard sliding hip screw device or X-Bolt at 10 U.K. centers.
3. A 100-patient randomized pilot study published in 2016, known as WHITE1, demonstrated a zero percent reoperation rate with the X-Bolt device compared to a 6 percent reoperation rate with the traditional sliding hip screw in unstable intertrochanteric hip fractures.
4. X-Bolt Orthopaedics is an Irish medical device company focused on developing hip nailing and plating solutions for hip fractures that require fixation.
More articles on devices:
5 things to know about the global XLIF surgery market & top competitors
Assure partners with 2 Louisiana spine surgeons
Spinal implants, surgical devices market to reach $18B by 2024 — 15 top companies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.